Clin2
NCT06576401Likely a fitRecruiting

HDM1002 metabolism study in healthy Chinese men

Healthy Adult Subject

This study tests how a new drug called HDM1002 leaves the body, using a tiny amount of a radioactive marker. It's for healthy men, and the results will help researchers understand how the drug works.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
10 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be a healthy male between 18 and 45 years old.
  • Your body mass index (BMI) must be between 19.0 and 32.0.
  • You must weigh at least 50 kilograms (about 110 pounds).
  • You cannot have any significant medical conditions, such as certain thyroid problems, pancreatitis, or stomach issues.
  • You cannot have taken any prescription drugs, over-the-counter medicines, or herbal supplements in the last 14 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06608329Not yet recruiting· Phase 1
Study of HDM1002: How it works with and without food

This study looks at how the drug HDM1002 is absorbed by the body, both when taken with food and on an empty stomach. It helps researchers understand the best way to take the medication.

Hangzhou, Zhejiang
NCT06562088Not yet recruiting· Phase 1
Study of HDM1002 drug interactions in healthy volunteers

This study tests how a new drug (HDM1002) interacts with two other common medicines—rifampin and itraconazole—in healthy volunteers. The results will help doctors understand how to safely use the drug with other medications.

Hefei, Anhui
NCT06601517Not yet recruiting· Phase 1
Study of drug interactions with HDM1002 in healthy and overweight adults

This trial tests how a new medicine, HDM1002, interacts with four common drugs (repaglinide, atorvastatin, digoxin, rosuvastatin) in healthy and overweight adults. The results will help guide safe dosing for future patients.

Beijing
NCT07594847Recruiting· Phase 1
Safety study of HDM1002 tablets on heart rhythm in healthy adults

This study tests whether a new experimental medication called HDM1002 affects how your heart beats in a healthy population. Researchers want to make sure the drug is safe before testing it in patients with actual medical conditions.

Zibo, Shangdong
NCT06985615Recruiting· Phase 1
Study of HDM1002 in people with and without liver problems

This trial tests a medicine called HDM1002 in people who have different levels of liver function. It aims to see how the liver affects the drug and if it is safe.

Suzhou, Jiangsu
NCT07516899Not yet recruiting· Phase 1
How Your Body Processes a New Experimental Drug

This study tests how a healthy male body absorbs, uses, and removes a new experimental medication. Researchers track the drug's path through your body using a special radioactive marker to understand how it works and ensure it's safe.

Wuxi, Jiangsu

Hear when a new Healthy Adult Subject trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.